RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Solid Biosciences Stock

Solid Biosciences P/S 2024

Solid Biosciences P/S

151.33

Ticker

SLDB

ISIN

US83422E2046

As of Jul 31, 2024, Solid Biosciences's P/S ratio stood at 151.33, a 0% change from the 0 P/S ratio recorded in the previous year.

The Solid Biosciences P/S history

Solid Biosciences Aktienanalyse

What does Solid Biosciences do?

Solid Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Solid Biosciences's P/S Ratio

Solid Biosciences's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Solid Biosciences's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Solid Biosciences's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Solid Biosciences’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Solid Biosciences stock

What is the price-to-earnings ratio of Solid Biosciences?

The price-earnings ratio of Solid Biosciences is currently 151.33.

How has the price-earnings ratio of Solid Biosciences changed compared to last year?

The price-to-earnings ratio of Solid Biosciences has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Solid Biosciences high compared to other companies?

Yes, the price-to-earnings ratio of Solid Biosciences is high compared to other companies.

How does an increase in the price-earnings ratio of Solid Biosciences affect the company?

An increase in the price-earnings ratio of Solid Biosciences would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Solid Biosciences affect the company?

A decrease in the price-earnings ratio of Solid Biosciences would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Solid Biosciences?

Some factors that influence the price-earnings ratio of Solid Biosciences are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Solid Biosciences pay?

Over the past 12 months, Solid Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Solid Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Solid Biosciences?

The current dividend yield of Solid Biosciences is .

When does Solid Biosciences pay dividends?

Solid Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Solid Biosciences?

Solid Biosciences paid dividends every year for the past 0 years.

What is the dividend of Solid Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Solid Biosciences located?

Solid Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Solid Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Solid Biosciences from 7/31/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Solid Biosciences pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Solid Biosciences in the year 2023?

In the year 2023, Solid Biosciences distributed 0 USD as dividends.

In which currency does Solid Biosciences pay out the dividend?

The dividends of Solid Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Solid Biosciences

Our stock analysis for Solid Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Solid Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.